A detailed history of Geode Capital Management, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 43,626 shares of ZLAB stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,626
Previous 34,519 26.38%
Holding current value
$1.19 Million
Previous $598,000 76.09%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$16.25 - $24.14 $147,988 - $219,842
9,107 Added 26.38%
43,626 $1.05 Million
Q2 2024

Aug 09, 2024

SELL
$13.72 - $21.55 $277,034 - $435,137
-20,192 Reduced 36.91%
34,519 $598,000
Q1 2024

May 13, 2024

BUY
$15.95 - $26.8 $4,147 - $6,968
260 Added 0.48%
54,711 $876,000
Q4 2023

Feb 13, 2024

SELL
$22.97 - $30.58 $24,371 - $32,445
-1,061 Reduced 1.91%
54,451 $1.49 Million
Q3 2023

Nov 13, 2023

SELL
$22.72 - $31.49 $357,862 - $495,998
-15,751 Reduced 22.1%
55,512 $1.35 Million
Q2 2023

Aug 11, 2023

SELL
$25.3 - $39.67 $9.94 Million - $15.6 Million
-392,870 Reduced 84.65%
71,263 $1.98 Million
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $232,435 - $370,081
7,694 Added 1.69%
464,133 $15.4 Million
Q4 2022

Feb 13, 2023

BUY
$22.28 - $38.71 $48,280 - $83,884
2,167 Added 0.48%
456,439 $14 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $1.12 Million - $1.69 Million
32,749 Added 7.77%
454,272 $15.5 Million
Q2 2022

Aug 12, 2022

BUY
$23.14 - $49.68 $1.22 Million - $2.61 Million
52,580 Added 14.25%
421,523 $14.6 Million
Q1 2022

May 13, 2022

BUY
$27.77 - $64.4 $346,347 - $803,196
12,472 Added 3.5%
368,943 $16.1 Million
Q4 2021

Feb 11, 2022

BUY
$54.9 - $105.21 $1.53 Million - $2.93 Million
27,896 Added 8.49%
356,471 $22.3 Million
Q3 2021

Nov 12, 2021

BUY
$105.0 - $178.37 $3.89 Million - $6.61 Million
37,048 Added 12.71%
328,575 $34.4 Million
Q2 2021

Aug 13, 2021

BUY
$125.11 - $180.0 $4.01 Million - $5.77 Million
32,041 Added 12.35%
291,527 $51.2 Million
Q1 2021

May 12, 2021

BUY
$126.27 - $191.71 $3.26 Million - $4.95 Million
25,795 Added 11.04%
259,486 $34.4 Million
Q4 2020

Feb 12, 2021

BUY
$81.94 - $135.34 $632,167 - $1.04 Million
7,715 Added 3.41%
233,691 $31.4 Million
Q3 2020

Nov 13, 2020

BUY
$73.3 - $89.48 $3.05 Million - $3.72 Million
41,569 Added 22.54%
225,976 $18.7 Million
Q2 2020

Aug 13, 2020

BUY
$48.82 - $82.53 $2.68 Million - $4.53 Million
54,861 Added 42.35%
184,407 $15.1 Million
Q1 2020

May 14, 2020

BUY
$39.1 - $62.9 $4.35 Million - $7 Million
111,254 Added 608.21%
129,546 $6.64 Million
Q3 2019

Nov 12, 2019

BUY
$30.47 - $37.65 $130,563 - $161,330
4,285 Added 30.59%
18,292 $591,000
Q1 2019

May 14, 2019

BUY
$21.71 - $31.54 $304,091 - $441,780
14,007 New
14,007 $413,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.67B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.